Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Professional Practice Guidelines for Personality Assessment.
J Pers Assess. 2022 Jan-Feb;104(1):1-16. doi: 10.1080/00223891.2021.1942020. Epub 2021 Jul 20.
J Pers Assess. 2022.
PMID: 34282964
Professional Practice Guidelines for Personality Assessment: Response to Comments by Ben-Porath (2022), Lui (2022), and Jenkins (2022).
Krishnamurthy R, Natoli AP, Arbisi PA, Hass GA, Gottfried ED.
Krishnamurthy R, et al. Among authors: hass ga.
J Pers Assess. 2022 Jan-Feb;104(1):27-29. doi: 10.1080/00223891.2021.2005075.
J Pers Assess. 2022.
PMID: 34941469
No abstract available.
Item in Clipboard
Using the MMPI-2 in Forensic Assessment: Response to Criticism About a Case Study.
Butcher JN, Hass GA, Greene RL, Nelson LD, Nichols DS, Williams CL.
Butcher JN, et al. Among authors: hass ga.
J Pers Assess. 2019 Mar-Apr;101(2):123-128. doi: 10.1080/00223891.2018.1493488. Epub 2018 Aug 17.
J Pers Assess. 2019.
PMID: 30118335
No abstract available.
Item in Clipboard
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees.
McMurray JJ, et al.
N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30.
N Engl J Med. 2014.
PMID: 25176015
Free article.
Clinical Trial.
Item in Clipboard
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.
Packer M, et al.
Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.
Circulation. 2015.
PMID: 25403646
Clinical Trial.
Item in Clipboard
Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Viigimaa M, Allikmets K, Parik T, Skards J, Franken A, Häss G.
Viigimaa M, et al.
Cardiovasc Drugs Ther. 2000 Aug;14(4):447-9. doi: 10.1023/a:1007876519124.
Cardiovasc Drugs Ther. 2000.
PMID: 10999653
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite